These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22985195)

  • 1. Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation.
    Bosch M; Dhadda M; Hoegh-Petersen M; Liu Y; Hagel LM; Podgorny P; Ugarte-Torres A; Khan FM; Luider J; Auer-Grzesiak I; Mansoor A; Russell JA; Daly A; Stewart DA; Maloney D; Boeckh M; Storek J
    Cytotherapy; 2012 Nov; 14(10):1258-75. PubMed ID: 22985195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation.
    Ito A; Kitano S; Tajima K; Kim Y; Tanaka T; Inamoto Y; Kim SW; Yamamoto N; Fukuda T; Okamoto S
    Int J Hematol; 2020 Jan; 111(1):120-130. PubMed ID: 31641956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
    Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
    Front Immunol; 2019; 10():334. PubMed ID: 30894856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis.
    Admiraal R; van Kesteren C; Jol-van der Zijde CM; Lankester AC; Bierings MB; Egberts TC; van Tol MJ; Knibbe CA; Bredius RG; Boelens JJ
    Lancet Haematol; 2015 May; 2(5):e194-203. PubMed ID: 26688094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of different doses of antithymocyte globulin conditioning on immune reconstitution upon hematopoietic stem cell transplantation.
    Li Y; Wang M; Fang X; Jiang Y; Sui X; Li Y; Liu X; Wang X; Lu D; Sun X; Xu H; Wang X
    Transpl Immunol; 2021 Dec; 69():101486. PubMed ID: 34678462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation.
    Waller EK; Langston AA; Lonial S; Cherry J; Somani J; Allen AJ; Rosenthal H; Redei I
    Biol Blood Marrow Transplant; 2003 Jul; 9(7):460-71. PubMed ID: 12869960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Following Flu-TBI versus TLI-ATG Conditioning.
    Hannon M; Beguin Y; Ehx G; Servais S; Seidel L; Graux C; Maertens J; Kerre T; Daulne C; de Bock M; Fillet M; Ory A; Willems E; Gothot A; Humblet-Baron S; Baron F
    Clin Cancer Res; 2015 Jul; 21(14):3131-9. PubMed ID: 25779951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-Based Antithymocyte Globulin in αβhaplo-Hematopoietic Stem Cell Transplantation Facilitates Engraftment, Expedites T Cell Recovery, and Mitigates the Risk of Acute Graft-versus-Host Disease.
    Barbarito G; Hiroshima L; Oppizzi L; Saini G; Kristovich K; Klein O; Hosszu K; Boehlke K; Gupta A; Mcavoy D; Shyr D; Boelens JJ; Bertaina A
    Transplant Cell Ther; 2024 Aug; 30(8):810.e1-810.e16. PubMed ID: 38768907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time series clustering of T cell subsets dissects heterogeneity in immune reconstitution and clinical outcomes among MUD-HCT patients receiving ATG or PTCy.
    Leserer S; Graf T; Franke M; Bogdanov R; Arrieta-Bolaños E; Buttkereit U; Leimkühler N; Fleischhauer K; Reinhardt HC; Beelen DW; Turki AT
    Front Immunol; 2023; 14():1082727. PubMed ID: 37020562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation.
    Servais S; Menten-Dedoyart C; Beguin Y; Seidel L; Gothot A; Daulne C; Willems E; Delens L; Humblet-Baron S; Hannon M; Baron F
    PLoS One; 2015; 10(6):e0130026. PubMed ID: 26098781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial.
    Gooptu M; Kim HT; Chen YB; Rybka W; Artz A; Boyer M; Johnston L; McGuirk J; Shea TC; Jagasia M; Shaughnessy PJ; Reynolds CG; Fields M; Alyea EP; Ho VT; Glavin F; Dipersio JF; Westervelt P; Ritz J; Soiffer RJ
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2216-2223. PubMed ID: 30006305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab.
    Willemsen L; Jol-van der Zijde CM; Admiraal R; Putter H; Jansen-Hoogendijk AM; Ostaijen-Ten Dam MM; Wijnen JT; van Kesteren C; Waaijer JL; Lankester AC; Bredius RG; van Tol MJ
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):473-82. PubMed ID: 25485863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector Reconstitution.
    Makanga DR; Guillaume T; Willem C; Legrand N; Gagne K; Cesbron A; Gendzekhadze K; Peterlin P; Garnier A; Le Bourgeois A; Béné MC; Chevallier P; Retière C
    J Immunol; 2020 Sep; 205(5):1441-1448. PubMed ID: 32747504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease.
    Khanolkar RA; Tripathi G; Dharmani-Khan P; Dabas R; Kinzel M; Kalra A; Puckrin R; Jimenez-Zepeda V; Jamani K; Duggan PR; Chaudhry A; Bryant A; Stewart DA; Khan FM; Storek J
    Cytotherapy; 2022 Dec; 24(12):1225-1231. PubMed ID: 36057497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune recovery and the role of recent thymic emigrated T lymphocytes after pediatric hematopoietic stem cell transplantation.
    Justus JLP; Beltrame MP; de Azambuja AP; Schluga YC; Martins EA; Rocha MTL; Rodrigues AM; Loth G; Lima ACM; Bonfim C
    Cytotherapy; 2024 Sep; 26(9):980-987. PubMed ID: 38762804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies.
    Cordón L; Chorão P; Martín-Herreros B; Montoro J; Balaguer A; Guerreiro M; Villalba M; Facal A; Asensi P; Solves P; Gómez I; Santiago M; Lamas B; Bataller A; Granados P; Sempere A; Sanz GF; Sanz MA; Sanz J
    Ann Hematol; 2024 Jul; 103(7):2475-2484. PubMed ID: 38634914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.
    Servais S; Lengline E; Porcher R; Carmagnat M; Peffault de Latour R; Robin M; Sicre de Fontebrune F; Clave E; Maki G; Granier C; Xhaard A; Dhedin N; Molina JM; Toubert A; Moins-Teisserenc H; Socie G
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):507-17. PubMed ID: 24406505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
    Lee KH; Lee JH; Lee JH; Kim DY; Park HS; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Baek S; Kang YL; Kim SH; Yun SC; Kim H; Jo JC; Choi Y; Joo YD; Lim SN
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1555-1566. PubMed ID: 28552421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabbit anti-T-lymphocyte globulin (ATG) persists with differential reactivity in patients' sera after full hematopoetic regeneration from allogeneic stem cell transplantation.
    Ziegler C; Finke J; Grüllich C
    Transpl Immunol; 2014 May; 30(4):136-9. PubMed ID: 24727089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients.
    Lakkaraja M; Mauguen A; Boulad F; Cancio MI; Curran KJ; Harris AC; Kernan NA; Klein E; Kung AL; Oved J; Prockop S; Scaradavou A; Spitzer B; O'Reilly RJ; Boelens JJ
    Cytotherapy; 2024 Apr; 26(4):351-359. PubMed ID: 38349310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.